Trending Content - Investment Banking Forum
| +67 | PWP acquisition by Piper cancelled | 27 | 1d |
| +60 | Is my MD a grifter? 16 years, 8 firms | 17 | 7h |
| +43 | No return offer - UPDATE. | 12 | 1d |
| +40 | Article: UBS Wall Street Rebuild Is a Study in Management Failure | 7 | 2d |
| +40 | "Corporate & Investment Banking" Analyst - Why? | 35 | 9m |
| +29 | Lack of talent in IB! | 25 | 11h |
| +28 | What Are The Best Boutiques 2026/2027 | 16 | 12h |
| +24 | Wells Fargo Calling Themselves a BB? | 16 | 14h |
| +24 | Moat of modelling in PE/Finance completely vanished; | 3 | 1d |
| +23 | Internal lateral from coverage to M&A (focused on coverage) | 8 | 2h |
Career Resources
SVB Securities
Not sure about ranking, but PJT, Cowen (Soon to be TD Cowen Securities), Jefferies, BAML, SVB. These are in no particular order. Not sure if MTS does anything in Life Sciences. Torreya is also there.
If you had to put it in a rank, what would it be like?
Maybe PJT, BAML, Jefferies/SVB, Cowen? Tbh i think you can rank these depending on the transaction type. M&A is probably PJT first for sure. I’m sorry, maybe someone else can be of more help for a pure ranking.
Edgemont, Cain, TripleTree
TripleTree is HC services and HCIT only. Starting to venture into pharma services and probably 5-10 years away from touching life sciences.
MTS does some really cool work in the Life Science space.
Does CVP do biopharma out of NYC or only SF?
Top Advisory - Centerview
Other Advisory: PJT/Evercore/Lazard/MTS
Mid-Market: SVB/Jefferies/Cowen/Piper
Other ok players: Guggenheim, Moelis, Oppenheimer, Cantor Fitzgerald, Torreya
PJT making a strong mark in the space..lead on Amgen’s 32bn in acquisitions this year + lead on 12bn CSL/ Vifor
Quis quia ut autem dolores aliquam. Quae voluptatem voluptatem est odit. Quod voluptatem voluptates odio est. Tempora minima veniam in harum. Eaque natus ea id nihil.
Sit et animi nisi dolores dolorem. Voluptatibus dolorum culpa vel iste sed dolores. Aspernatur modi animi consequatur ducimus. Qui autem ratione nihil neque nemo sint optio.
Atque quibusdam similique ipsam culpa nisi occaecati error. Porro distinctio aliquid rerum sequi aut maiores maxime error. Numquam ut et itaque quia aut. Molestiae aut accusamus dignissimos voluptatem illo est. Quidem esse id provident et aspernatur soluta qui sint.
Explicabo ea beatae excepturi. Occaecati distinctio repellat repudiandae quia quis. Consequatur in animi ut autem omnis et id. Nemo laboriosam nihil repellat repellendus quis et excepturi aut. Totam voluptatem voluptas possimus vel. Vel culpa quidem earum non sequi quia sed repudiandae.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...